{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T06:41:39Z","timestamp":1764398499076,"version":"3.46.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009392","name":"Prince Sattam Bin Abdulaziz University","doi-asserted-by":"crossref","award":["PSAU\/2025\/1445"],"award-info":[{"award-number":["PSAU\/2025\/1445"]}],"id":[{"id":"10.13039\/100009392","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10822-025-00685-2","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T03:17:13Z","timestamp":1761621433000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Discovery and validation of pyrrolopyrimidine-based VEGFR2 inhibitors targeting tumor angiogenesis via structure-based virtual screening, quantum chemical analysis, and in vitro assays"],"prefix":"10.1007","volume":"39","author":[{"given":"Ahmed I.","family":"Foudah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aftab","family":"Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"685_CR1","unstructured":"NCI (2024) Cancer Statistics (Accessed 20 Sep 2024). https:\/\/www.cancer.gov\/about-cancer\/understanding\/statistics"},{"key":"685_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/B978-0-323-90190-1.00007-X","volume-title":"Antiangiogenic drugs as chemosensitizers in cancer therapy","author":"R Petrioli","year":"2022","unstructured":"Petrioli R, Miano ST, Martellucci I (2022) Antiangiogenic agents in the treatment of colorectal, gastric, and gastroesophageal junction adenocarcinoma. Antiangiogenic drugs as chemosensitizers in cancer therapy. Academic Press, pp 67\u201378"},{"key":"685_CR3","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","volume":"77","author":"R Lugano","year":"2020","unstructured":"Lugano R, Ramachandran M, Dimberg A (2020) Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell Mol Life Sci CMLS 77:1745\u20131770. https:\/\/doi.org\/10.1007\/s00018-019-03351-7","journal-title":"Cell Mol Life Sci CMLS"},{"key":"685_CR4","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19:1423\u20131437. https:\/\/doi.org\/10.1038\/nm.3394","journal-title":"Nat Med"},{"key":"685_CR5","doi-asserted-by":"publisher","first-page":"100009","DOI":"10.1016\/j.medidd.2019.100009","volume":"2","author":"SJ Modi","year":"2019","unstructured":"Modi SJ, Kulkarni VM (2019) Vascular endothelial growth factor receptor (VEGFR-2)\/KDR inhibitors: medicinal chemistry perspective. Med Drug Discov 2:100009. https:\/\/doi.org\/10.1016\/j.medidd.2019.100009","journal-title":"Med Drug Discov"},{"key":"685_CR6","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1177\/1947601911423031","volume":"2","author":"M Shibuya","year":"2011","unstructured":"Shibuya M (2011) Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies. Genes Cancer 2:1097\u20131105. https:\/\/doi.org\/10.1177\/1947601911423031","journal-title":"Genes Cancer"},{"key":"685_CR7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.bbrc.2011.04.093","volume":"410","author":"HM Jopling","year":"2011","unstructured":"Jopling HM, Howell GJ, Gamper N, Ponnambalam S (2011) The VEGFR2 receptor tyrosine kinase undergoes constitutive endosome-to-plasma membrane recycling. Biochem Biophys Res Commun 410:170\u2013176. https:\/\/doi.org\/10.1016\/j.bbrc.2011.04.093","journal-title":"Biochem Biophys Res Commun"},{"key":"685_CR8","first-page":"87","volume":"2","author":"H Momtaz","year":"2015","unstructured":"Momtaz H, Seifati SM, Tavakol M (2015) Determining the prevalence and detection of the most prevalent virulence genes in acinetobacter baumannii isolated from hospital infections. Ssu-Ijml 2:87\u201397","journal-title":"Ssu-Ijml"},{"key":"685_CR9","doi-asserted-by":"publisher","first-page":"a008656","DOI":"10.1101\/cshperspect.a008656","volume":"5","author":"DR McIlwain","year":"2013","unstructured":"McIlwain DR, Berger T, Mak TW (2013) Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol 5:a008656. https:\/\/doi.org\/10.1101\/cshperspect.a008656","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"685_CR10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3390\/jpm12030327","volume":"12","author":"I Maiborodin","year":"2022","unstructured":"Maiborodin I, Mansurova A, Chernyavskiy A et al (2022) Cancer angiogenesis and opportunity of influence on tumor by changing vascularization. J Pers Med 12:327. https:\/\/doi.org\/10.3390\/jpm12030327","journal-title":"J Pers Med"},{"key":"685_CR11","doi-asserted-by":"publisher","first-page":"105131","DOI":"10.1016\/j.bioorg.2021.105131","volume":"114","author":"AS Girgis","year":"2021","unstructured":"Girgis AS, Panda SS, Srour AM et al (2021) 3-alkenyl-2-oxindoles: Synthesis, antiproliferative and antiviral properties against SARS-CoV-2. Bioorg Chem 114:105131. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105131","journal-title":"Bioorg Chem"},{"key":"685_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.critrevonc.2010.02.012","volume":"77","author":"FAB Schutz","year":"2011","unstructured":"Schutz FAB, Choueiri TK, Sternberg CN (2011) Pazopanib: clinical development of a potent anti-angiogenic drug. Crit Rev Oncol Hematol 77:163\u2013171. https:\/\/doi.org\/10.1016\/j.critrevonc.2010.02.012","journal-title":"Crit Rev Oncol Hematol"},{"key":"685_CR13","doi-asserted-by":"publisher","first-page":"115672","DOI":"10.1016\/j.bcp.2023.115672","volume":"214","author":"M Van Daele","year":"2023","unstructured":"Van Daele M, Kilpatrick LE, Woolard J, Hill SJ (2023) Characterisation of tyrosine kinase inhibitor-receptor interactions at VEGFR2 using sunitinib-red and nanobret. Biochem Pharmacol 214:115672. https:\/\/doi.org\/10.1016\/j.bcp.2023.115672","journal-title":"Biochem Pharmacol"},{"key":"685_CR14","doi-asserted-by":"publisher","first-page":"1288652","DOI":"10.3389\/fmolb.2023.1288652","volume":"10","author":"S Baammi","year":"2023","unstructured":"Baammi S, El Allali A, Daoud R (2023) Potent VEGFR-2 inhibitors for resistant breast cancer: a comprehensive 3D-QSAR, ADMET, molecular docking and MMPBSA calculation on triazolopyrazine derivatives. Front Mol Biosci 10:1288652. https:\/\/doi.org\/10.3389\/fmolb.2023.1288652","journal-title":"Front Mol Biosci"},{"key":"685_CR15","doi-asserted-by":"publisher","first-page":"104694","DOI":"10.1016\/j.compbiomed.2021.104694","volume":"136","author":"SS Antunes","year":"2021","unstructured":"Antunes SS, Won-Held Rabelo V, Romeiro NC (2021) Natural products from Brazilian biodiversity identified as potential inhibitors of PknA and PknB of M. tuberculosis using molecular modeling tools. Comput Biol Med 136:104694. https:\/\/doi.org\/10.1016\/j.compbiomed.2021.104694","journal-title":"Comput Biol Med"},{"key":"685_CR16","doi-asserted-by":"publisher","first-page":"112783","DOI":"10.1016\/j.ejmech.2020.112783","volume":"208","author":"G Li Petri","year":"2020","unstructured":"Li Petri G, Span\u00f2 V, Spatola R et al (2020) Bioactive pyrrole-based compounds with target selectivity. Eur J Med Chem 208:112783. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112783","journal-title":"Eur J Med Chem"},{"key":"685_CR17","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.2174\/0929867324666170303162100","volume":"24","author":"F Musumeci","year":"2017","unstructured":"Musumeci F, Sanna M, Grossi G et al (2017) Pyrrolo[2,3-d]pyrimidines as kinase inhibitors. Curr Med Chem 24:2059\u20132085. https:\/\/doi.org\/10.2174\/0929867324666170303162100","journal-title":"Curr Med Chem"},{"key":"685_CR18","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c00204","author":"K Frankowski","year":"2022","unstructured":"Frankowski K, Patnaik S, Wang C et al (2022) Discovery and optimization of pyrrolopyrimidine derivatives as selective disruptors of the perinucleolar compartment, a marker of tumor progression toward metastasis. J Med Chem. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00204","journal-title":"J Med Chem"},{"key":"685_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z et al (2000) The Protein Data Bank. Nucleic Acids Res 28:235\u2013242. https:\/\/doi.org\/10.1093\/nar\/28.1.235","journal-title":"Nucleic Acids Res"},{"key":"685_CR20","doi-asserted-by":"publisher","first-page":"7260","DOI":"10.1016\/j.bmc.2010.08.017","volume":"18","author":"Y Oguro","year":"2010","unstructured":"Oguro Y, Miyamoto N, Okada K et al (2010) Design, synthesis, and evaluation of 5-methyl-4-phenoxy-5H-pyrrolo[3,2-d]pyrimidine derivatives: novel VEGFR2 kinase inhibitors binding to inactive kinase conformation. Bioorg Med Chem 18:7260\u20137273. https:\/\/doi.org\/10.1016\/j.bmc.2010.08.017","journal-title":"Bioorg Med Chem"},{"key":"685_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-020-00478-9","volume":"13","author":"M Sorokina","year":"2021","unstructured":"Sorokina M, Merseburger P, Rajan K et al (2021) COCONUT online: Collection of open natural products database. J Cheminform 13:2. https:\/\/doi.org\/10.1186\/s13321-020-00478-9","journal-title":"J Cheminform"},{"key":"685_CR22","doi-asserted-by":"publisher","first-page":"28446","DOI":"10.1021\/acsomega.5c04340","volume":"10","author":"L Silva Franco","year":"2025","unstructured":"Silva Franco L, Rodrigues DA, Baumart GJ et al (2025) Drug repurposing by virtual screening: identification of new already approved ROCK inhibitors as promising drugs to target neurodegeneration. ACS Omega 10:28446\u201328465. https:\/\/doi.org\/10.1021\/acsomega.5c04340","journal-title":"ACS Omega"},{"key":"685_CR23","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.3390\/molecules26123631","volume":"26","author":"AM Deghady","year":"2021","unstructured":"Deghady AM, Hussein RK, Alhamzani AG, Mera A (2021) Density functional theory and molecular docking investigations of the chemical and antibacterial activities for 1-(4-hydroxyphenyl)-3-phenylprop-2-en-1-one. Molecules 26:3631. https:\/\/doi.org\/10.3390\/molecules26123631","journal-title":"Molecules"},{"key":"685_CR24","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3390\/molecules27030620","volume":"27","author":"NT El-Shamy","year":"2022","unstructured":"El-Shamy NT, Alkaoud AM, Hussein RK et al (2022) DFT, ADMET and molecular docking investigations for the antimicrobial activity of 6,6\u2019-diamino-1,1\u2019,3,3\u2019-tetramethyl-5,5\u2019-(4-chlorobenzylidene)bis[pyrimidine-2,4(1H,3H)-dione]. Molecules 27:620. https:\/\/doi.org\/10.3390\/molecules27030620","journal-title":"Molecules"},{"key":"685_CR25","doi-asserted-by":"crossref","unstructured":"Bowers KJ, Chow E, Xu H, et al (2006) Scalable algorithms for molecular dynamics simulations on commodity clusters. pp 84-es","DOI":"10.1145\/1188455.1188544"},{"key":"685_CR26","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1021\/acs.jctc.3c00039","volume":"19","author":"S Boothroyd","year":"2023","unstructured":"Boothroyd S, Behara PK, Madin OC et al (2023) Development and benchmarking of open force field 2.0.0: the sage small molecule force field. J Chem Theory Comput 19:3251\u20133275. https:\/\/doi.org\/10.1021\/acs.jctc.3c00039","journal-title":"J Chem Theory Comput"},{"key":"685_CR27","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1021\/jp003020w","volume":"105","author":"P Mark","year":"2001","unstructured":"Mark P, Nilsson L (2001) Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K. J Phys Chem A 105:9954\u20139960. https:\/\/doi.org\/10.1021\/jp003020w","journal-title":"J Phys Chem A"},{"key":"685_CR28","doi-asserted-by":"publisher","first-page":"122210","DOI":"10.1016\/j.physa.2019.122210","volume":"534","author":"O Farago","year":"2019","unstructured":"Farago O (2019) Langevin thermostat for robust configurational and kinetic sampling. Phys A Stat Mech Appl 534:122210","journal-title":"Phys A Stat Mech Appl"},{"key":"685_CR29","doi-asserted-by":"publisher","first-page":"124108","DOI":"10.1063\/1.4978807","volume":"146","author":"Y Lin","year":"2017","unstructured":"Lin Y, Pan D, Li J et al (2017) Application of Berendsen barostat in dissipative particle dynamics for nonequilibrium dynamic simulation. J Chem Phys 146:124108. https:\/\/doi.org\/10.1063\/1.4978807","journal-title":"J Chem Phys"},{"key":"685_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/978-1-62703-658-0_11","volume-title":"protein dynamics: methods and protocols","author":"CC David","year":"2014","unstructured":"David CC, Jacobs DJ (2014) Principal component analysis: a method for determining the essential dynamics of proteins. In: Livesay DR (ed) protein dynamics: methods and protocols. Humana Press, Totowa, pp 193\u2013226"},{"key":"685_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-1-62703-398-5_4","volume-title":"Protein-ligand interactions: methods and applications","author":"L Damian","year":"2013","unstructured":"Damian L (2013) Isothermal titration calorimetry for studying protein-ligand interactions. In: Williams MA, Daviter T (eds) Protein-ligand interactions: methods and applications. Humana Press, Totowa, pp 103\u2013118"},{"key":"685_CR32","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.3390\/jcm8101602","volume":"8","author":"I Kocherova","year":"2019","unstructured":"Kocherova I, Bryja A, Mozdziak P et al (2019) Human umbilical vein endothelial cells (HUVECs) co-culture with osteogenic cells: from molecular communication to engineering prevascularised bone grafts. J Clin Med 8:1602. https:\/\/doi.org\/10.3390\/jcm8101602","journal-title":"J Clin Med"},{"key":"685_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/B978-0-12-803077-6.00009-6","volume-title":"Basic science methods for clinical researchers","author":"CP Segeritz","year":"2017","unstructured":"Segeritz CP, Vallier L (2017) Basic science methods for clinical researchers. Academic Press, pp 151\u2013172"},{"issue":"23","key":"685_CR34","doi-asserted-by":"publisher","first-page":"12827","DOI":"10.3390\/ijms222312827","volume":"22","author":"M Ghasemi","year":"2021","unstructured":"Ghasemi M, Turnbull T, Sebastian S, Kempson I (2021) The MTT assay: utility, limitations, pitfalls, and interpretation in bulk and single-cell analysis. Int J Mol Sci 22(23):12827","journal-title":"Int J Mol Sci"},{"key":"685_CR35","doi-asserted-by":"crossref","unstructured":"De Lano WL (2002) CCP4 Newsl Protein Crystallogr 40(1):82\u201392","DOI":"10.1007\/3-540-45732-1_10"},{"key":"685_CR36","unstructured":"BIOVIA (2017) Discovery Studio Visualizer. https:\/\/discover.3ds.com\/discovery-studio-visualizer-download"},{"key":"685_CR37","doi-asserted-by":"publisher","first-page":"663","DOI":"10.12688\/f1000research.24143.1","volume":"9","author":"B Br","year":"2020","unstructured":"Br B, Damle H, Ganju S, Damle L (2020) In silico screening of known small molecules to bind ACE2 specific RBD on spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19. F1000Res 9:663. https:\/\/doi.org\/10.12688\/f1000research.24143.1","journal-title":"F1000Res"},{"key":"685_CR38","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1080\/07391102.2022.2036241","volume":"41","author":"G Yalcin-Ozkat","year":"2023","unstructured":"Yalcin-Ozkat G, Ersan RH, Ulger M et al (2023) Design, synthesis, and computational studies of benzimidazole derivatives as new antitubercular agents. J Biomol Struct Dyn 41:2667\u20132686. https:\/\/doi.org\/10.1080\/07391102.2022.2036241","journal-title":"J Biomol Struct Dyn"},{"key":"685_CR39","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/jcb.30232","volume":"123","author":"R Alexey","year":"2022","unstructured":"Alexey R, Dariya S, Liudmyla I et al (2022) Structure-based virtual screening and biological evaluation of novel inhibitors of mycobacterium Z-ring formation. J Cell Biochem 123:852\u2013862. https:\/\/doi.org\/10.1002\/jcb.30232","journal-title":"J Cell Biochem"},{"key":"685_CR40","first-page":"24","volume":"5","author":"MJ Yunta","year":"2017","unstructured":"Yunta MJ (2017) It is important to compute intramolecular hydrogen bonding in drug design. Am J Model Optim 5:24\u201357","journal-title":"Am J Model Optim"},{"key":"685_CR41","doi-asserted-by":"publisher","first-page":"103753","DOI":"10.1016\/j.sjbs.2023.103753","volume":"30","author":"ZK Bagewadi","year":"2023","unstructured":"Bagewadi ZK, Yunus Khan TM, Gangadharappa B et al (2023) Molecular dynamics and simulation analysis against superoxide dismutase (SOD) target of Micrococcus luteus with secondary metabolites from Bacillus licheniformis recognized by genome mining approach. Saudi J Biol Sci 30:103753. https:\/\/doi.org\/10.1016\/j.sjbs.2023.103753","journal-title":"Saudi J Biol Sci"},{"key":"685_CR42","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U (2015) The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 10:449\u2013461. https:\/\/doi.org\/10.1517\/17460441.2015.1032936","journal-title":"Expert Opin Drug Discov"},{"key":"685_CR43","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/minf.201100135","volume":"31","author":"N Homeyer","year":"2012","unstructured":"Homeyer N, Gohlke H (2012) Free energy calculations by the molecular mechanics Poisson-Boltzmann surface area method. Mol Inform 31:114\u2013122. https:\/\/doi.org\/10.1002\/minf.201100135","journal-title":"Mol Inform"},{"key":"685_CR44","doi-asserted-by":"publisher","first-page":"106425","DOI":"10.1016\/j.bioorg.2023.106425","volume":"133","author":"X-J Liu","year":"2023","unstructured":"Liu X-J, Zhao H-C, Hou S-J et al (2023) Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy. Bioorg Chem 133:106425. https:\/\/doi.org\/10.1016\/j.bioorg.2023.106425","journal-title":"Bioorg Chem"},{"issue":"19","key":"685_CR45","doi-asserted-by":"publisher","first-page":"6203","DOI":"10.3390\/molecules27196203","volume":"27","author":"EB Elkaeed","year":"2022","unstructured":"Elkaeed EB, Yousef RG, Khalifa MM et al (2022) Discovery of new VEGFR-2 inhibitors: design, synthesis, anti-proliferative evaluation, docking, and MD simulation studies. Molecules 27(19):6203. https:\/\/doi.org\/10.3390\/molecules27196203","journal-title":"Molecules"},{"issue":"21","key":"685_CR46","doi-asserted-by":"publisher","first-page":"15858","DOI":"10.1021\/acs.jmedchem.1c01168","volume":"64","author":"SM Cho","year":"2021","unstructured":"Cho SM, Kim Y, Jung Y et al (2021) Development of novel VEGFR2 inhibitors originating from natural product analogues with antiangiogenic impact. J Med Chem 64(21):15858\u201315867. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c01168","journal-title":"J Med Chem"},{"key":"685_CR47","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.3390\/ijms19051334","volume":"19","author":"K Ballmer-Hofer","year":"2018","unstructured":"Ballmer-Hofer K, Hyde CAC, Schleier T, Avramovic D (2018) ScFvs as allosteric inhibitors of VEGFR-2: novel tools to harness VEGF signaling. Int J Mol Sci 19:1334. https:\/\/doi.org\/10.3390\/ijms19051334","journal-title":"Int J Mol Sci"},{"key":"685_CR48","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.3390\/ijms19041264","volume":"19","author":"CJ Peach","year":"2018","unstructured":"Peach CJ, Mignone VW, Arruda MA et al (2018) Molecular pharmacology of VEGF-A isoforms: binding and signalling at VEGFR2. Int J Mol Sci 19:1264. https:\/\/doi.org\/10.3390\/ijms19041264","journal-title":"Int J Mol Sci"},{"key":"685_CR49","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3978\/j.issn.2305-5839.2014.08.14","volume":"2","author":"C Fontanella","year":"2014","unstructured":"Fontanella C, Ongaro E, Bolzonello S et al (2014) Clinical advances in the development of novel VEGFR2 inhibitors. Ann Transl Med 2:123. https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2014.08.14","journal-title":"Ann Transl Med"},{"key":"685_CR50","doi-asserted-by":"publisher","first-page":"6759","DOI":"10.3390\/molecules26226759","volume":"26","author":"X Ye","year":"2021","unstructured":"Ye X, Gaucher J-F, Vidal M, Broussy S (2021) A structural overview of vascular endothelial growth factors pharmacological ligands: from macromolecules to designed peptidomimetics. Molecules 26:6759. https:\/\/doi.org\/10.3390\/molecules26226759","journal-title":"Molecules"},{"issue":"Suppl 1","key":"685_CR51","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.3816\/cbc.2000.s.015","volume":"1","author":"HM Verheul","year":"2000","unstructured":"Verheul HM, Pinedo HM (2000) The role of vascular endothelial growth factor (VEGF) in tumor angiogenesis and early clinical development of VEGF-receptor kinase inhibitors. Clin Breast Cancer 1(Suppl 1):S80-84. https:\/\/doi.org\/10.3816\/cbc.2000.s.015","journal-title":"Clin Breast Cancer"},{"key":"685_CR52","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2174\/1568011033353452","volume":"3","author":"S Shinkaruk","year":"2003","unstructured":"Shinkaruk S, Bayle M, La\u00efn G, D\u00e9l\u00e9ris G (2003) Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy. Curr Med Chem Anti-Cancer Agents 3:95\u2013117. https:\/\/doi.org\/10.2174\/1568011033353452","journal-title":"Curr Med Chem Anti-Cancer Agents"},{"key":"685_CR53","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1634\/theoncologist.2014-0465","volume":"20","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Adjei AA (2015) Targeting angiogenesis in cancer therapy: moving beyond vascular endothelial growth factor. Oncologist 20:660\u2013673. https:\/\/doi.org\/10.1634\/theoncologist.2014-0465","journal-title":"Oncologist"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00685-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00685-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00685-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T06:38:25Z","timestamp":1764398305000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00685-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["685"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00685-2","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"type":"print","value":"0920-654X"},{"type":"electronic","value":"1573-4951"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"17 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"109"}}